It means the FDA hasn't reviewed Trimi's specific compounded formulations for safety, effectiveness, or quality before they reach you
While there is no known dangerous interaction between alcohol and GLP-1 medications, studies have found that many people naturally reduce their alcohol intake after starting treatment without intending to because the medication seems to lower the desire for it
However, these side effects werent confirmed to be associated with the treatment and could have been a coincidence and not related to the use of semaglutide
Similarly, exendin-4 injection into the VMH of mice also reduced food intake and body weight, but, interestingly, decreased energy expenditureunlike liraglutide injectiondespite both acting via AMPK inhibition [99]
NEJM Dec 2025) 12 None (no approved label) MTC thyroid C-cell (rodent, human relevance unestablished) 28 None published None published Once weekly, subcutaneous Once weekly, subcutaneous US: late 2027 earliest (NDA Q4 2026 at soonest) 22 Already approved (US: 2022/2023/2024